Renaissance Technologies LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 6:09 pm Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Renaissance Technologies LLC | 714,400 3.480% |
-319,500 (-30.90%) |
Filing |
| 2021-02-10 12:19 pm Purchase |
2020-09-18 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Renaissance Technologies LLC | 1,033,900 5.130% |
1,033,900 (New Position) |
Filing |